Monday, 21 February 2022 Reading time : 1 minute

Despite the recent drop in Meta Platforms' share price, 7 of the world's 10 most valuable companies are still domiciled in the USA. The 5 largest among them are currently the following companies: Apple (USD 2.8 trill.), Microsoft (USD 2.2 trill.), Alphabet (USD 1.8 trill.), Amazon (USD 1.6 trill.) and Tesla (USD 906.7 billion).

But Swiss companies do not have to hide in terms of market capitalization either. Nestlé (CHF 330 billion), Roche (CHF 282 billion), Novartis (CHF 194 billion), Richemont (CHF 75 billion) and UBS (CHF 69 billion) stand out here.

Large caps are typically industry leaders in their respective sectors and thus offer a certain degree of stability. The combination of these industry leaders creates attractive coupons even at very low barriers.

Callable BRC on Apple, Microsoft, Alphabet, Amazon and Tesla (USD / CHF)

• 19.5% / 18.5% p.a. Coupon
• 50% barrier
• 12 months Term
• Subscription period until February 25, 2022
• Termsheet USD / CHF

BRC on Apple, Microsoft, Alphabet, Amazon and Tesla (USD / CHF)

• 15.25% / 14.25% p.a. Coupon
• 50% Barrier
• 12 months Term
• Subscription period until February 25, 2022
• Termsheet USD / CHF

Callable BRC on Nestlé, Novartis, Roche, Richemont and UBS (CHF)

• 7.75% p.a. Coupon
• 50% Barrier
• 12 months Term
• Subscription period until February 25, 2022
• Termsheet

BRC on Nestlé, Novartis, Roche, Richemont and UBS (CHF)

• 5.5% p.a. Coupon
• 50% Barrier
• 12 months Term
• Subscription period until February 25, 2022
• Termsheet

Our leverage products on these companies can be found here.

All information is indicative and without guarantee. Market data as of February 18, 2022

 

Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.